Laura Napoleone

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Urine Proteomics in Cirrhosis and Acute Kidney Injury: Insights Into the Pathogenesis of Hepatorenal Syndrome.

Urine Proteomics in Cirrhosis and Acute Kidney Injury: Insights Into the Pathogenesis of Hepatorenal Syndrome.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 16, 2025

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Journal: JAMA

Published: February 05, 2025

Changes of in-vivo markers of platelet activation during the menstrual cycle in healthy pre-menopausal female individuals.

Changes of in-vivo markers of platelet activation during the menstrual cycle in healthy pre-menopausal female individuals.

Journal: Communications medicine

Published: December 02, 2024

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.

Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.

Journal: Journal of hepatology

Published: September 14, 2023

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.

Journal: PloS one

Published: November 24, 2021

Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome.

Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome.

Journal: Hepatology communications

Published: November 09, 2021

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis.

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis.

Journal: Journal of clinical medicine

Published: September 29, 2021

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.

Journal: Hepatology communications

Published: May 28, 2021

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

Journal: Journal of hepatology

Published: May 27, 2021

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 09, 2021

Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 04, 2020

Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.

Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.

Journal: Gastroenterology

Published: March 16, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026